Federal grant · project grant (b)

Revel Pharmaceuticals Inc.

An Enzyme-based Assay for the Detection of Acetaldehyde-protein Adducts - Abstract Chronic Alcohol Consumption Is a Significant Issue Worldwide Which Can Lead to Addiction and Damage Throughout the Body. the First Step in Alcohol Metabolism Is Its Conversion Into Acetaldehyde, Which Is a Highly Reactive and Toxic Molecule. the Formation of Acetaldehyde Adducts With Protein and Dna Is a Primary Mechanism of Ethanol Toxicity. Acetaldehyde Adducts Are a Direct Biomarker for Alcohol Abuse. We Intend to Develop a Facile and Rapid Enzyme-based Assay for Measuring Acetaldehyde-protein Adducts to Assess Alcohol Use and Alcohol-related Health Consequences.

Committed

$272,118

Paid to

UEI RBFMLGKG8KZ3

2325 3RD ST Ste 214, San Francisco, CA, 94107

Department of Health and Human Services

National Institutes of Health

Place

CA, UNITED STATES

Performance

Aug 1, 2023 → Jul 31, 2024

How to read these numbers

One award, start to finish: Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed vs. ceiling: Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
Paid out: The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
The ledger: Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
The money bar: One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .

Source

This award on USAspending.gov ↗

Federal grant · project grant (b)

Department of Health and Human Services

National Institutes of Health

Alcohol Research Programs to

Revel Pharmaceuticals Inc.

Committed

$272,118

Paid to

Revel Pharmaceuticals Inc.

UEI RBFMLGKG8KZ3

2325 3RD ST Ste 214, San Francisco, CA, 94107

Department of Health and Human Services

National Institutes of Health

Place

CA, UNITED STATES

Performance

Aug 1, 2023 → Jul 31, 2024

How to read these numbers

One award, start to finish: Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed vs. ceiling: Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
Paid out: The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
The ledger: Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
The money bar: One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .

Source

This award on USAspending.gov ↗